Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Etropal ADXBUL:ETR 50 Days Inventory is 112.72 as of Dec. 2025, which is 42% below its 10-year median of 194.02. GuruFocus rates XBUL:ETR with a GF Score™ of 50/100 and a GF Value™ of €8.66 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Etropal AD ranks better than 75.95% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Etropal AD's Average Total Inventories for the
six
months ended in Dec. 2025 was €2.23 Mil. Etropal AD's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €7.21 Mil.
Hence, Etropal AD's Days Inventory for the
six
months ended in Dec. 2025 was 56.36.
The historical rank and industry rank for Etropal AD's Days Inventory or its related term are showing as below:
XBUL:ETR'
s Days Inventory Range Over the Past 10 Years
Min: 105.85 Med: 194.02 Max: 370.48
Current: 112.72
During the past 13 years, Etropal AD's highest Days Inventory was 370.48. The lowest was 105.85. And the median was 194.02.
XBUL:ETR's Days Inventory is ranked better than 75.95% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs XBUL:ETR: 112.72
Etropal AD's Days Inventory
declined
from Dec. 2023 (120.48) to Dec. 2025 (112.72).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Etropal AD's Inventory Turnover for the
six
months ended in Dec. 2025 was 3.24.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Etropal AD's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.22.
Etropal AD (XBUL:ETR) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Etropal AD's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Etropal AD's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Etropal AD Days Inventory Related Terms
Etropal AD Days Inventory Historical Data
* Premium members only.
The historical data trend for Etropal AD's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XBUL:ETR vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Etropal AD's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Etropal AD Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Etropal AD's Days Inventory distribution charts can be found below:
* The bar in red indicates where Etropal AD's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Etropal AD (XBUL:ETR) has a Days Inventory of 112.72 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Etropal AD and its competitors. This is 42% below median its historical median of 194.02. Over the past decade, Etropal AD's Days Inventory has ranged from 105.85 to 370.48. According to the industry distribution chart, Etropal AD ranks #189 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 24%.
Is Etropal AD's Days Inventory too high?
Etropal AD's current Days Inventory of 112.72 is 42% below median its 10-year median of 194.02. Over the past 10 years, this metric has ranged from a low of 105.85 to a high of 370.48. The Medical Devices & Instruments industry median Days Inventory is 179.60. Etropal AD's value of 112.72 is 37.2% below this industry median. Based on the distribution chart, Etropal AD ranks #189 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Etropal AD has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Etropal AD's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Etropal AD ranks #189 out of 786 companies for Days Inventory. This places Etropal AD in the top 24% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.60. Etropal AD's value of 112.72 is 37.2% below this benchmark. Historically, Etropal AD's own Days Inventory has ranged from 105.85 to 370.48 over the past decade. While the company's 10-year median is 194.02 vs. the industry median of 179.60, Etropal AD has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Etropal AD's current Days Inventory of 112.72 is 37.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Etropal AD and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Etropal AD's current Days Inventory is 112.72, which is 42% below median its own 10-year median of 194.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Etropal AD stock overvalued right now?
Based on GuruFocus' analysis, Etropal AD (XBUL:ETR) is currently considered Significantly Undervalued. The stock's GF Value™ is €8.66, compared to a current price of €2.76 — trading 68.1% below its estimated fair value. The current Days Inventory is 112.72, which is 42% below median its 10-year median of 194.02 and 37.2% below the Medical Devices & Instruments industry median of 179.60. Etropal AD's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Etropal AD (XBUL:ETR), the current Days Inventory is 112.72 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Etropal AD (XBUL:ETR) Overvalued in 2026?
Based on GuruFocus' analysis, Etropal AD stock appears to be undervalued.
The current stock price of €2.76 is trading 68.1% below its estimated GF Value™ of €8.66.
GuruFocus considers Etropal AD to be Significantly Undervalued.
Key valuation signals for XBUL:ETR:
Days Inventory: 112.72 (42% below median its 10-year median of 194.02)
GF Value™: €8.66 vs. price of €2.76 (68.1% below fair value)
Industry Position: 37.2% below the Medical Devices & Instruments median (#189 of 786)
No single metric tells the full story. See the XBUL:ETR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Etropal AD is engaged in the business of manufacturing medical accessories. The product portfolio includes fistula needles, blood taking sets, transfusion and infusion sets, catheters and tubes, urine collecting bags, colostomy bags, among others. The company also produces hip - joint endoprosthesis and instruments of implantation.
50GF Score
Get the complete analysis for XBUL:ETR
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBUL:ETR has been successfully added to your 
